B1

COMBINATION_PRODUCT2 trials

Sponsors

Breath of Life International Pharma Ltd, Huashan Hospital

Conditions

HealthyMultidrug Resistant TuberculosisPre-XDR-TBRifampicin Resistant Tuberculosis

Phase 1

A Phase I Open Label Study to Assess PK and Safety of Plant Cannabis Extract

CompletedNCT04261166

Breath of Life International Pharma LtdHealthy

Start: 2019-07-24End: 2022-10-24Updated: 2022-12-08

Phase 3

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

RecruitingNCT05081401

Huashan HospitalMultidrug Resistant Tuberculosis, Pre-XDR-TB, Rifampicin Resistant Tuberculosis

Start: 2022-05-23End: 2027-12-01Target: 1050Updated: 2025-04-06

Related Papers

Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic randomised controlled trial

BMC Infectious Diseases2026-03-17